PharmGen Science, Inc.
004720 | KO
Overview
Corporate Details
- ISIN(s):
- KR7004720009
- LEI:
- Country:
- South Korea
- Address:
- 경기 화성시 향남면 상신리 향남제약공단 902-5, 화성시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-19 00:00 |
Interim / Quarterly Report
[기재정정]반기보고서 (2025.06)
|
Korean | 1.4 MB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.4 MB | ||
| 2025-08-12 00:00 |
Share Issue/Capital Change
전환청구권ㆍ신주인수권ㆍ교환청구권행사
|
Korean | 15.9 KB | ||
| 2025-06-12 00:00 |
Share Issue/Capital Change
전환청구권ㆍ신주인수권ㆍ교환청구권행사
|
Korean | 14.0 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.8 MB | ||
| 2025-04-14 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-04-14 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.9 KB | ||
| 2025-04-14 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.9 KB | ||
| 2025-04-14 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 26.0 KB | ||
| 2025-04-14 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 110.0 KB | ||
| 2025-04-11 00:00 |
Share Issue/Capital Change
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
|
Korean | 14.4 KB | ||
| 2025-04-10 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 677.5 KB | ||
| 2025-04-03 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-04-03 00:00 |
Major Shareholding Notification
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 34.9 KB | ||
| 2025-03-31 00:00 |
AGM Information
정기주주총회결과
|
Korean | 28.6 KB |
Automate Your Workflow. Get a real-time feed of all PharmGen Science, Inc. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for PharmGen Science, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PharmGen Science, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
A clinical-stage company developing broad-spectrum vaccines for bacterial infectious diseases.
United States of America
PCVX
United States of America
PCVX
Develops, manufactures, and distributes consumer self-care products and medical devices globally.
United Kingdom
VLG
United Kingdom
VLG
Clinical-stage biopharma developing oral therapies for autoimmune, inflammatory & neuro diseases.
United States of America
VTYX
United States of America
VTYX
Develops cancer medicines targeting the RAS/MAPK pathway, with an approved therapy for ovarian cancer.
United States of America
VSTM
United States of America
VSTM
Develops autologous cell therapies for sports medicine and severe burn care markets.
United States of America
VCEL
United States of America
VCEL
Develops innovative therapies for chronic respiratory diseases like COPD and asthma.
United States of America
VRNA
United States of America
VRNA
Develops topical therapies for skin diseases like molluscum contagiosum and common warts.
United States of America
VRCA
United States of America
VRCA
Develops transformative medicines for serious diseases, specializing in cystic fibrosis.
United States of America
VRTX
United States of America
VRTX
Biopharma firm developing drugs for cardiometabolic and inflammatory diseases.
United States of America
VERU
United States of America
VERU
Develops and markets veterinary drugs and products for companion animals and livestock worldwide.
France
VETO
France
VETO